Aspen Pharmacare – is the market rating the share price too low? Read the long-term Mergence houseview by Portfolio Manager Izak van Niekerk.
The Magnificent Seven: looking beyond the hype
With the build-out of data centres not losing steam, the AI trade continues to command investors’ attention. But beneath the
